These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25446760)

  • 1. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
    Philbert J; Beeské S; Belzung C; Griebel G
    Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
    Philbert J; Belzung C; Griebel G
    Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
    Philbert J; Pichat P; Palme R; Belzung C; Griebel G
    Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: a mouse model of post-traumatic stress disorder (PTSD).
    Philbert J; Pichat P; Beeské S; Decobert M; Belzung C; Griebel G
    Behav Brain Res; 2011 Aug; 221(1):149-54. PubMed ID: 21377492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.
    Nedelcovych MT; Gould RW; Zhan X; Bubser M; Gong X; Grannan M; Thompson AT; Ivarsson M; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2015 Mar; 6(3):485-93. PubMed ID: 25581551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M; Suzuki M; Shimizu K
    Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses.
    Prajapati SK; Krishnamurthy S
    Behav Brain Res; 2021 Feb; 399():113015. PubMed ID: 33212086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
    Ahnaou A; Steckler T; Heylen A; Kennis L; Nakazato A; Chaki S; Drinkenburg WH
    Eur J Pharmacol; 2012 Apr; 680(1-3):63-8. PubMed ID: 22314225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
    Kantor S; Varga J; Kulkarni S; Morton AJ
    Neurotherapeutics; 2017 Oct; 14(4):1120-1133. PubMed ID: 28653279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
    Overstreet DH; Griebel G
    Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.
    Dournes C; Beeské S; Belzung C; Griebel G
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():213-20. PubMed ID: 23367508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe and protracted sleep disruptions in mouse model of post-traumatic stress disorder.
    Sharma R; Sahota P; Thakkar MM
    Sleep; 2018 Mar; 41(3):. PubMed ID: 29346627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The α1 adrenoceptor antagonist prazosin enhances sleep continuity in fear-conditioned Wistar-Kyoto rats.
    Laitman BM; Gajewski ND; Mann GL; Kubin L; Morrison AR; Ross RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():7-15. PubMed ID: 24246572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine regulation of sleep disturbances in PTSD.
    Neylan TC; Otte C; Yehuda R; Marmar CR
    Ann N Y Acad Sci; 2006 Jul; 1071():203-15. PubMed ID: 16891571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
    Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
    Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats.
    Knapp DJ; Overstreet DH; Huang M; Wills TA; Whitman BA; Angel RA; Sinnett SE; Breese GR
    Psychopharmacology (Berl); 2011 Nov; 218(1):179-89. PubMed ID: 21643675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.